As both SAD and CKD increase intrarenal angiotensin II (Shan et al., 2004; Vaziri et al., 2007), we can speculate that a greater activation of RAS in SAD+CKD may prevent a greater reduction of GFR in this group. Here, AGT is linked to chronic kidney disease.